Literature DB >> 14576046

Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.

Norbert Gattermann1, Michael Wulfert, Bärbel Junge, Ulrich Germing, Rainer Haas, Götz Hofhaus.   

Abstract

In a patient with refractory anemia with excess blasts (RAEB), a somatic mutation of mitochondrial transfer RNA(Leu(UUR)) was detected in bone marrow cells. Heteroduplex analysis indicated that 40% to 50% of mitochondrial DNA (mtDNA) molecules in the bone marrow (BM) carried the novel G3242A mutation. The proportion of mutant mtDNA was higher in CD34(+) cells than in the unfractionated sample. Surprisingly, the mutation was not detectable by heteroduplex analysis in the peripheral blood (PB). However, PB CD34(+) cells selected by immunomagnetic beads harbored the mutation with a proportion of approximately 50%. In hematopoietic colony assays, CD34(+) cells from BM and PB yielded only colonies with wild-type mtDNA. These results indicate that the mtDNA mutation in CD34(+) cells was associated with a maturation defect. Mitochondrial tRNA mutations impair mitochondrial protein synthesis, thereby causing dysfunction of the mitochondrial respiratory chain. We propose that this effect contributed to ineffective hematopoiesis in our patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576046     DOI: 10.1182/blood-2003-07-2446

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Mouse models of myelodysplastic syndromes.

Authors:  Sarah H Beachy; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

2.  Enhanced growth of myelodysplastic colonies in hypoxic conditions.

Authors:  James Edwin Thompson; Joseph Patrick Conlon; Xiaowei Yang; Patricia Vanessa Sanchez; Martin Carroll
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

3.  Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction.

Authors:  Michael L Chen; T Daniel Logan; Maryann L Hochberg; Suresh G Shelat; Xiang Yu; Gregory E Wilding; Wei Tan; Gregory C Kujoth; Tomas A Prolla; Mary A Selak; Mondira Kundu; Martin Carroll; James E Thompson
Journal:  Blood       Date:  2009-09-04       Impact factor: 22.113

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

5.  SOD2 deficient erythroid cells up-regulate transferrin receptor and down-regulate mitochondrial biogenesis and metabolism.

Authors:  Florent M Martin; Xiuling Xu; Katharina von Löhneysen; Timothy J Gilmartin; Jeffrey S Friedman
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

6.  Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.

Authors:  Yan Guo; Amma Bosompem; Sanjay Mohan; Begum Erdogan; Fei Ye; Kasey C Vickers; Quanhu Sheng; Shilin Zhao; Chung-I Li; Pei-Fang Su; Madan Jagasia; Stephen A Strickland; Elizabeth A Griffiths; Annette S Kim
Journal:  BMC Genomics       Date:  2015-09-24       Impact factor: 3.969

7.  Disease-associated mutations in mitochondrial precursor tRNAs affect binding, m1R9 methylation, and tRNA processing by mtRNase P.

Authors:  Agnes Karasik; Catherine A Wilhelm; Carol A Fierke; Markos Koutmos
Journal:  RNA       Date:  2020-12-30       Impact factor: 4.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.